| 000 | 01791 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250516092516.0 | ||
| 264 | 0 | _c20121001 | |
| 008 | 201210s 0 0 eng d | ||
| 022 | _a1945-2403 | ||
| 024 | 7 |
_a10.1093/jat/bks042 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEsposito, Francis M | |
| 245 | 0 | 0 |
_aEvaluation of the 20% D-methamphetamine requirement for determining illicit use of methamphetamine in urine. _h[electronic resource] |
| 260 |
_bJournal of analytical toxicology _cJul 2012 |
||
| 300 |
_a399-404 p. _bdigital |
||
| 500 | _aPublication Type: Evaluation Study; Journal Article | ||
| 650 | 0 | 4 | _aAdministration, Inhalation |
| 650 | 0 | 4 |
_aCentral Nervous System Stimulants _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Contamination |
| 650 | 0 | 4 |
_aDrug and Narcotic Control _xmethods |
| 650 | 0 | 4 | _aGuidelines as Topic |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunoassay |
| 650 | 0 | 4 |
_aIndicators and Reagents _xchemistry |
| 650 | 0 | 4 | _aLaboratory Proficiency Testing |
| 650 | 0 | 4 | _aLimit of Detection |
| 650 | 0 | 4 |
_aMethamphetamine _xadministration & dosage |
| 650 | 0 | 4 |
_aNasal Decongestants _xadministration & dosage |
| 650 | 0 | 4 |
_aNonprescription Drugs _xadministration & dosage |
| 650 | 0 | 4 |
_aProline _xanalogs & derivatives |
| 650 | 0 | 4 | _aStereoisomerism |
| 650 | 0 | 4 |
_aSubstance Abuse Detection _xstandards |
| 650 | 0 | 4 | _aUnited States |
| 650 | 0 | 4 | _aUnited States Dept. of Health and Human Services |
| 650 | 0 | 4 | _aUnited States Substance Abuse and Mental Health Services Administration |
| 700 | 1 | _aCrumpton, Susan | |
| 700 | 1 | _aMitchell, John | |
| 700 | 1 | _aFlegel, Ronald R | |
| 773 | 0 |
_tJournal of analytical toxicology _gvol. 36 _gno. 6 _gp. 399-404 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/jat/bks042 _zAvailable from publisher's website |
| 999 |
_c21781593 _d21781593 |
||